At the news
? NEUTRALIMPACT 3/10 CLUSTER filed May 3, 2026 at 20:00 ET
Insmed's CEO and CMO sold a combined $1.27M in stock within a week of a strong Q1 2026 earnings beat (revenue up 230% YoY, EPS beat). The CMO's sale ($1.22M) is a cash-out following option exercises; the CEO's sale ($58K) is routine. At 0.005% of market cap, the total is trivial and likely liquidity-driven, not a bearish signal.
- CEO William Lewis sold 433 shares for ~$58K on May 4, 2026.
- CMO Martina Flammer sold 12,119 shares for ~$1.22M on May 11, 2026, following option exercises.
- Total cluster value of $1.27M represents ~0.005% of INSM's $25.1B market cap.
- Q1 2026 revenue of $306M (up 230% YoY) and EPS beat consensus; BRINSUPRI guidance reiterated at ≥$1B.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access